We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
VERSACLOZ (clozapine) 50 mg/mL oral suspension (TruPharma)
Section 19A approved medicine
VERSACLOZ (clozapine) 50 mg/mL oral suspension (TruPharma)
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 00 8422 348
Phone
1800 675 229
Approved until
Status
Current
Medicines in short supply/unavailable
CLOPINE SUSPENSION clozapine 50 mg/mL oral liquid bottle - ARTG 142239
Indication(s)
Treatment with VERSACLOZ is indicated only in people with treatment-resistant schizophrenia, i.e. people with schizophrenia who are non-responsive to, or intolerant of other antipsychotic drugs.
Images
